Comparison

Vonafexor European Partner

Item no. TMO-T8471-50mg
Manufacturer TargetMol
CASRN 1192171-69-9
Amount 50mg
Category
Type Molecules
Specific against other
Purity 100.00%
Citations Fiorucci S,et al. Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH) [published online ahead of print, 2020 Jun 19]. Expert Opin Investig Drugs. 2020;1-10.
Smiles OC(=O)C1=CC2=C(O1)C=CC(N1CCN(CC1)S(=O)(=O)C1=C(Cl)C=CC=C1Cl)=C2Cl
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1192171-69-9, FXR, pxl007 , PLX007 , EYP001
Available
Short Description
Vonafexor is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects
Shipping
cool pack
Storage
-20°
Target names or alias
pxl007 , PLX007 , EYP001
Molecular Weight
489, 76
Pathway
Microbiology/Virology|||Metabolism
Target
FXR|||HBV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close